Coherus Oncology Inc (CHRS)

Net Income

-$20.63M

Quarterly · Period ending: · USD

CHRS logo

CHRS Net Income

Latest reported-$20.63M
CHRS Quarterly Net Income (-$8.86M → -$20.63M)
High-resolution chart · PNG

CHRS net income history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Net Income — Quarterly (USD)
Period endingNet Income (USD)
-20,631,000
-37,939,000
-37,278,000
-35,109,000
-41,335,000
-56,569,000
-50,696,000
-10,751,000
-12,921,000
102,875,000
-79,653,000
-39,641,000
-42,869,000
-75,729,000
-58,870,000
-86,650,000
-50,150,000
-96,084,000
-45,725,000
-38,528,000
-29,900,000
-172,947,000
9,708,000
27,933,000
59,031,000
35,572,000
39,227,000
47,043,000
23,567,000
-20,004,000
-62,596,000
-58,808,000
-43,638,000
-44,297,000
-49,067,000
-58,989,000
-55,336,000
-74,778,000
-75,921,000
83,939,000
-69,967,000
-65,388,000
-52,391,000
-71,334,000
-58,810,000
-40,725,000
-29,134,000
-7,872,000
-24,957,000
-25,170,000
-14,591,000
-21,473,000
-8,709,000
-8,862,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.